GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Sale Of Property, Plant, Equipment

CGON (CG Oncology) Sale Of Property, Plant, Equipment : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Sale Of Property, Plant, Equipment?

CG Oncology's sale of property, plant, equipment for the three months ended in Dec. 2024 was $0.00 Mil. It means CG Oncology gained $0.00 Mil from selling property, plant, and equipment. CG Oncology's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Sep. 2024 ), CG Oncology gained the same money from selling property, plant, and equipment in Dec. 2024 ($0.00 Mil).


CG Oncology Sale Of Property, Plant, Equipment Historical Data

The historical data trend for CG Oncology's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Sale Of Property, Plant, Equipment Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Sale Of Property, Plant, Equipment
- - - -

CG Oncology Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CG Oncology Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CG Oncology Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of CG Oncology's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


CG Oncology Business Description

Industry
Traded in Other Exchanges
N/A
Address
400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.